Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Christopher A Blevins"'
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0206639 (2018)
Leptospirosis is a worldwide veterinary and public health concern, and well recognized infectious disease of horses. Seroprevalence rates vary with geography, but many studies have confirmed a high exposure rate. The correlation between seropositivit
Externí odkaz:
https://doaj.org/article/25626eb812ba47908adc91df657140f4
Autor:
Ian Hargraves, Kristyn Maixner, David A. Katzka, Rajesh Krishnamoorthi, Prasad G. Iyer, Christopher H. Blevins, Michele L. Johnson, Naveen Gopalakrishnan, Jayant A. Talwalkar, Harshith Priyan, Annie LeBlanc, Kenneth K. Wang
Publikováno v:
Journal of Clinical Gastroenterology. 55:36-42
Goals To develop an encounter decision aid [Barrett's esophagus Choice (BE-Choice)] for patients and clinicians to engage in shared decision making (SDM) for management of BE with low-grade dysplasia (BE-LGD) and assess its impact on patient-importan
Autor:
Prasad G. Iyer, Christopher H Blevins, Ramona Lansing, David A. Katzka, Ying Gibbens, Michele L. Johnson
Publikováno v:
Am J Gastroenterol
Introduction We assessed if obesity perturbs the esophageal epithelial barrier function independent of promotion of gastroesophageal reflux (GER). Methods Thirty-eight participants were divided into 4 groups: Obesity-/GER-, Obesity+/GER-, Obesity-/GE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98429a4e876853f508af432f813b5cd4
https://europepmc.org/articles/PMC8243777/
https://europepmc.org/articles/PMC8243777/
Autor:
Ying Gibbens, Ramona Lansing, Prasad G. Iyer, Michele Johnson, David A. Katzka, Christopher H. Blevins, Harshith Priyan
Publikováno v:
American Journal of Gastroenterology. 115:S178-S178
Autor:
Gregory G. Ginsberg, Jason T. Lewis, Anil K. Rustgi, Christopher H. Blevins, Denis Wigle, Adharsh Ravindran, Fouad Otaki, Ross A. Dierkhising, Gary W. Falk, Timothy C. Wang, Michele L. Johnson, Anna Krigel, Kenneth K. Wang, Hiroshi Nakagawa, Cadman L. Leggett, Charles J. Lightdale, Prasad G. Iyer, Naveen Gopalakrishnan, Julian A. Abrams, Gene K. Ma
Publikováno v:
Gastrointestinal Endoscopy. 92:31-39.e1
Background and Aims The treatment of submucosal (T1b) esophageal adenocarcinoma (EAC) remains in evolution, with some evidence supporting endoscopic management of low-risk lesions. Using a multicenter cohort, we evaluated outcomes of patients with T1
Autor:
Karthik Ravi, David A. Katzka, Ross A. Dierkhising, Christopher H. Blevins, Prasad G. Iyer, Michele L. Johnson, Marcelo F. Vela, Debra M. Geno
Publikováno v:
Neurogastroenterology & Motility. 30
Background The mechanism by which obesity leads to damage independent of reflux is unclear. We aimed to determine the influence of obesity on mean nocturnal baseline impedance (MNBI), a functional measure of the epithelial barrier, in the presence an
Publikováno v:
Journal of clinical gastroenterology. 52(10)
GOALS: To determine patient preference for Barrett’s esophagus (BE) screening techniques. BACKGROUND: Sedated endoscopy (sEGD) and unsedated transnasal endoscopy (uTNE) are both potential techniques for BE screening. However systematic assessment o
Autor:
Prasad G. Iyer, Christopher H. Blevins
Publikováno v:
Gastrointestinal endoscopy clinics of North America. 27(3)
Despite the availability of safe and effective endoscopic treatment of Barrett's esophagus (BE)-related dysplasia and neoplasia, the incidence and mortality from esophageal adenocarcinoma (EAC) have continued to increase. This likely stems from the l
Autor:
James P. Moriarty, David A. Katzka, Kenneth K. Wang, Michele Johnson, Joel H. Rubenstein, Prasad G. Iyer, Christopher H. Blevins, Louis Michel Wongkeesong, Nilay Shah, David A. Ahlquist
Background and Aims Data on the economic impact associated with screening for Barrett's esophagus (BE) are limited. As part of a comparative effectiveness randomized trial of unsedated transnasal endoscopy (uTNE) and sedated EGD (sEGD), we assessed c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c5b1d363394215e594066ce300601e
https://europepmc.org/articles/PMC5656556/
https://europepmc.org/articles/PMC5656556/
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 16(5)
Dysfunction in the esophageal epithelial barrier function is a major source for morbidity. To better understand the pathophysiologic pathways of the diseases associated with barrier dysfunction, including gastroesophageal reflux disease, eosinophilic